Research finds high cost and randomness in grant funding decisions

September 28, 2011 in Medical research

(PhysOrg.com) -- Which scientific health and medical research projects receive government funding in any given year relies to some extent on 'chance' according to recent research by a Queensland University of Technology (QUT) expert in health economics.

Professor Nicholas Graves of QUT's Institute for Health and Biomedical Innovation (IHBI) has found high cost and randomness are features of the current system, which is based on a peer review process.

His research will be published in the today (Wednesday September 28, 2011).

"The key problem is that the current process is overloaded with information and a reliable ranking based on peer review is difficult to achieve," he said. "The quality of peer review is known to be variable at the best of times.

"The composition of peer review committees themselves is somewhat arbitrary, depending upon who has been invited to take part and who is available. This affects funding decisions because the personalities, preferences and knowledge of committee members will vary.

"In many cases in order to get funded an applicant will have to write a really good proposal and be lucky."

Professor Graves said the National Health and Medical Research Council of Australia (NHMRC) committed $754 million to health and medical grants in 2009 and he based his research on 2705 of the 2983 project grant proposals received that year.

"We found 'chance' played a role in funding decisions yet at the same time these decisions have a huge impact on the careers of academics," he said.

"The current funding process is also costly and time consuming to participate in.

"With the average grant application taking 22 days to write at a cost $17,744 each, a total of 180 years of research time was used up in 2009 to prepare applications at a cost of $50 million, most of which was borne by applicants."

Professor Graves said with success rates for grant proposals falling worldwide and funding agency budgets expected to be flat or reduced over the next five to 10 years as the government cut back on spending in order to reduce national debt, it was important to look at the cost and the effectiveness of current funding processes.

He said it may be sensible to shorten applications so they are easier to prepare and easier to review.

"At the moment an application can be over 70 pages long and include a nine page research plan," he said.

He called for more research into ways to improve the process.

"While it would cost money to conduct this research it's likely to be only a drop in the ocean compared with total research money allocated by research funding bodies in any one year," Professor Graves said.

Chair of the NHMRC Council Professor Michael Good said: "It would be interesting to think about other ways of allocating research funding, by assessing an applicant's actual research performance, including published papers, new policies or observable improvements in health, as opposed to promises of research to come."

Professor Wayne Hall, an NHMRC Australia fellow said: "The policy of excluding some experts from due to a perceived conflict of interest is problematic... the result is that those who know about the quality of the research are asked to leave the room when it is discussed."

Provided by Queensland University of Technology search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

H. pylori, smoking trends, and gastric cancer in US men

Trends in Helicobacter pylori (H. pylori) and smoking explain a significant proportion of the decline of intestinal-type noncardia gastric adenocarcinoma (NCGA) incidence in US men between 1978 and 2008, and are estimated ...

Medical research created 7 hours ago | popularity not rated yet | comments 0

Common food supplement fights degenerative brain disorders

Widely available in pharmacies and health stores, phosphatidylserine is a natural food supplement produced from beef, oysters, and soy. Proven to improve cognition and slow memory loss, it's a popular treatment for older ...

Medical research created 11 hours ago | popularity 5 / 5 (2) | comments 0 | with audio podcast

Finding a family for a pair of orphan receptors in the brain

Researchers at Emory University have identified a protein that stimulates a pair of "orphan receptors" found in the brain, solving a long-standing biological puzzle and possibly leading to future treatments for neurological ...

Medical research created 12 hours ago | popularity 5 / 5 (1) | comments 0 | with audio podcast

Insight into the dazzling impact of insulin in cells

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.

Medical research created 12 hours ago | popularity 4.5 / 5 (6) | comments 0 | with audio podcast

Do men's and women's hearts burn fuel differently?

Researchers at the University of Illinois at Chicago College of Medicine will study gender differences in how the heart uses and stores fat—its main energy source—and how changes in fat metabolism play ...

Medical research created 15 hours ago | popularity not rated yet | comments 0


If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...

New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Antidepressant reduces stress-induced heart condition

A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.

Drugs found to both prevent and treat Alzheimer's disease in mice

Researchers at USC have found that a class of pharmaceuticals can both prevent and treat Alzheimer's Disease in mice.